Significant fluctuations are estimated for all segments over the forecast period for the revenue. The indicator decreases towards the end of the forecast period only in the segment Sensory Organs Drugs, while the remaining segments follow a positive trend. The difference between 2018 and 2029 amounts to an absolute value of 199.22 million U.S. dollars.
Data provided by Statista Market Insights are estimates.
Definition: The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.
Structure: The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.
Additional information: Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).
Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista Market Insights. (June 26, 2024). Revenue in the Pharmaceuticals market for different segments Japan from 2018 to 2029 (in million U.S. dollars) [Graph]. In Statista. Retrieved November 04, 2024, from https://www.statista.com/forecasts/1443755/revenue-pharmaceuticals-market-for-different-segments-japan
Statista Market Insights. "Revenue in the Pharmaceuticals market for different segments Japan from 2018 to 2029 (in million U.S. dollars)." Chart. June 26, 2024. Statista. Accessed November 04, 2024. https://www.statista.com/forecasts/1443755/revenue-pharmaceuticals-market-for-different-segments-japan
Statista Market Insights. (2024). Revenue in the Pharmaceuticals market for different segments Japan from 2018 to 2029 (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 04, 2024. https://www.statista.com/forecasts/1443755/revenue-pharmaceuticals-market-for-different-segments-japan
Statista Market Insights. "Revenue in The Pharmaceuticals Market for Different Segments Japan from 2018 to 2029 (in Million U.S. Dollars)." Statista, Statista Inc., 26 Jun 2024, https://www.statista.com/forecasts/1443755/revenue-pharmaceuticals-market-for-different-segments-japan
Statista Market Insights, Revenue in the Pharmaceuticals market for different segments Japan from 2018 to 2029 (in million U.S. dollars) Statista, https://www.statista.com/forecasts/1443755/revenue-pharmaceuticals-market-for-different-segments-japan (last visited November 04, 2024)
Revenue in the Pharmaceuticals market for different segments Japan from 2018 to 2029 (in million U.S. dollars) [Graph], Statista Market Insights, June 26, 2024. [Online]. Available: https://www.statista.com/forecasts/1443755/revenue-pharmaceuticals-market-for-different-segments-japan